Mukka Proteins reported a strong fiscal year with consolidated revenue up 44% to ₹1,449.5 crore and profit up 18.7% to ₹57.1 crore. The company acquired two entities and secured a major waste management contract but recommended no dividend.
Mukka Proteins Reports Strong FY26 Growth, Acquires New Entities
**Revenue: ₹1,449.5 crore (up 44% YoY)** **Profit After Tax: ₹57.1 crore (up 18.7% YoY)** Reader Takeaway: Diversified growth in new segments is a positive, but increasing leverage and contract dependence are key watch points. ## What just happened Mukka Proteins Ltd has announced its financial results for the fiscal year 2025-26, showcasing significant year-on-year growth. The company's consolidated revenue surged by 44.0% to ₹1,449.5 crore, and Profit After Tax (PAT) increased by 18.7% to ₹57.1 crore. The Board has decided not to recommend any dividend for FY 2025-26. Key corporate developments include the successful acquisition of 100% stakes in Ento Proteins Private Limited and Haris Marine Products Private Limited. Additionally, the company secured a substantial ₹474.89 crore contract from Bengaluru Solid Waste Management Limited for leachate treatment. ## Why this matters The strong financial performance, driven by acquisitions and a significant new order in the waste management sector, indicates successful business diversification. This growth is crucial for Mukka Proteins as it expands beyond its traditional marine products business. However, the company's increased borrowings and reliance on large contracts warrant attention from investors. ## The backstory Mukka Proteins, known for its marine-based animal feed, has been actively expanding its portfolio. The recent acquisitions of Ento Proteins and Haris Marine are part of this strategy to enter new segments like insect-based protein and value-added marine products. The company is also focusing on waste management solutions, with its Bengaluru initiative recognized by Verra Registry. An international expansion with a facility in Oman is also underway. ## What changes now The successful integration of the acquired entities and the execution of the large waste management contract are expected to drive future revenue streams. The development of the Oman facility signals international ambitions. The company's board members have been recommended for re-appointment, subject to shareholder approval at the upcoming AGM on September 10, 2026. ## Risks to watch Mukka Proteins faces risks related to commodity prices and availability of raw materials, which are subject to seasonal factors and potential El Niño impacts. The company also noted that its current borrowings exceed its total equity, leading to increased leverage. Furthermore, newer business verticals are currently dependent on a limited number of large contracts, posing a concentration risk. ## Peer comparison (No direct peer comparison data available in the filing.) ## Context metrics (time-bound) - The company's consolidated revenue stood at ₹1,006.4 crore in FY 2024-25. - Consolidated EBITDA for FY 2025-26 was ₹145.3 crore, a 30.9% increase from ₹111.2 crore in FY 2024-25. - EBITDA margin for FY26 was 10.0%. - The company diverted over 1,00,000 tonnes of wet waste from landfills in the current fiscal. ## What to track next Investors will be watching the performance of the newly acquired subsidiaries, Ento Proteins and Haris Marine. The successful execution of the ₹474.89 crore waste management contract and the progress of the Oman manufacturing facility are also key areas to monitor. The company's leverage position and any potential impact on its credit rating, which was recently downgraded by CARE Ratings to CARE BBB; Negative, will be critical.
